TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 78 filers reported holding TANGO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,093,800 | +239.2% | 630,000 | 0.0% | 2.17% | +491.6% |
| Q2 2023 | $2,091,600 | -15.9% | 630,000 | 0.0% | 0.37% | -28.6% |
| Q1 2023 | $2,488,500 | -45.5% | 630,000 | 0.0% | 0.51% | -47.7% |
| Q4 2022 | $4,567,500 | +100.2% | 630,000 | 0.0% | 0.98% | +84.8% |
| Q3 2022 | $2,281,000 | -20.1% | 630,000 | 0.0% | 0.53% | -30.1% |
| Q2 2022 | $2,854,000 | -40.2% | 630,000 | 0.0% | 0.76% | -36.7% |
| Q1 2022 | $4,775,000 | -30.7% | 630,000 | 0.0% | 1.20% | -10.1% |
| Q4 2021 | $6,892,000 | -23.9% | 630,000 | -10.0% | 1.34% | -5.8% |
| Q3 2021 | $9,051,000 | – | 700,000 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |